Overview

A Clinical Trial of Safety and Efficacy of Fasudil in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Status:
Unknown status
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This study will examine whether fasudil is effective and safe in treating patients with amyotrophic lateral sclerosis (ALS).
Phase:
Phase 2
Details
Lead Sponsor:
Peking University Third Hospital
Treatments:
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
Fasudil